Since previous, immunohistochemical findings clearly showed that MT-I/II and megalin were overexpressed particularly in HSIL (CIN2 and CIN3/CIS), by double immunofluorescence, we further attempted to visualize the possible co-localization of MT-I/II and megalin in affected cervical regions. The gene discussed is LRP2; the disease is in situ carcinoma.